---
title: "Argent Biopharma Issues 2.5 Million Unquoted Performance Rights Under Incentive Scheme"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/279884725.md"
description: "Argent Biopharma Issues 2.5 Million Unquoted Performance Rights Under Incentive Scheme"
datetime: "2026-03-20T04:18:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/279884725.md)
  - [en](https://longbridge.com/en/news/279884725.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/279884725.md)
---

# Argent Biopharma Issues 2.5 Million Unquoted Performance Rights Under Incentive Scheme

Argent Biopharma Issues 2.5 Million Unquoted Performance Rights Under Incentive Scheme

### Related Stocks

- [ABVC.US](https://longbridge.com/en/quote/ABVC.US.md)
- [LABU.US](https://longbridge.com/en/quote/LABU.US.md)
- [PBE.US](https://longbridge.com/en/quote/PBE.US.md)
- [BBH.US](https://longbridge.com/en/quote/BBH.US.md)
- [AMAM.US](https://longbridge.com/en/quote/AMAM.US.md)
- [XBI.US](https://longbridge.com/en/quote/XBI.US.md)
- [LSBCF.US](https://longbridge.com/en/quote/LSBCF.US.md)
- [SBIO.US](https://longbridge.com/en/quote/SBIO.US.md)
- [FBT.US](https://longbridge.com/en/quote/FBT.US.md)
- [IXJ.US](https://longbridge.com/en/quote/IXJ.US.md)
- [ARKG.US](https://longbridge.com/en/quote/ARKG.US.md)
- [IBB.US](https://longbridge.com/en/quote/IBB.US.md)
- [BIB.US](https://longbridge.com/en/quote/BIB.US.md)

## Related News & Research

- [Immix Biopharma Announces 95% Complete Response Rate In Interim Update From Relapsed/Refractory AL Amyloidosis Clinical Trial NEXICART-2](https://longbridge.com/en/news/287200923.md)
- [Co-Diagnostics Advances Ebola Preparedness With New Bundibugyo Virus Assay Strategy; Stock Up](https://longbridge.com/en/news/286956797.md)
- [Guardant Health Says US FDA Approved Liquid Biopsy Test](https://longbridge.com/en/news/287069625.md)
- [Korro Bio To Advance KRRO-111 As Potential Treatment For AATD](https://longbridge.com/en/news/287089978.md)
- [ImmunityBio Expands Bladder Cancer Arsenal With Exclusive Japanese BCG Partnership](https://longbridge.com/en/news/286787574.md)